Onartuzumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Onartuzumab
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target scatter factor receptor kinase
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
Formula C4422H6820N1168O1363S31
Molar mass 99.1 kg/mol
 NYesY (what is this?)  (verify)

Onartuzumab is a humanized monoclonal antibody designed for the treatment of cancer.[1]

Onartuzumab was developed by Genentech, Inc.

References[edit]

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Onartuzumab" (PDF). American Medical Association.